A Study of RC48-ADC in Subjects With HER2 Overexpressed Metastatic Biliary Tract Cancer
Condition(s):Biliary Tract CancerLast Updated:October 12, 2020Recruiting
Hide Studies Not Open or Pending
Condition(s):Biliary Tract CancerLast Updated:October 12, 2020Recruiting
Condition(s):HER2-Positive Solid TumorsLast Updated:February 21, 2020Not yet recruiting
Condition(s):Solid TumorsLast Updated:June 4, 2020Completed
Condition(s):Solid TumorsLast Updated:July 30, 2020Completed
Condition(s):Urothelial CarcinomaLast Updated:December 17, 2020Active, not recruiting
Condition(s):Gastric Cancer; HER2 Overexpressing Gastric CarcinomaLast Updated:January 19, 2021Not yet recruiting
Condition(s):Urothelial CarcinomaLast Updated:August 3, 2020Recruiting
Condition(s):Urothelial Carcinoma; Advanced CancerLast Updated:August 21, 2019Completed
Condition(s):Urothelial CarcinomaLast Updated:February 13, 2020Recruiting
Condition(s):Gastric Cancer; HER2 Overexpressing Gastric CarcinomaLast Updated:June 9, 2020Active, not recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.